TNFRSF1A and obesity disorder: Although this result was not confirmed by a subsequent trial (Kritikou et al. [52], 2 months of CPAP), the hypothesis remains intriguing, as TNFR-1 is a highly sensitive inflammatory marker that plays a significant role in glucose homeostasis and the development of obesity [4].